Semi-Sequential Assay for Anti-Drug Antibody Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for detecting anti-drug antibodies in samples suffer from low signal-to-noise ratios, low sensitivity, and prozone effects, which hinder accurate detection and assessment of immunogenicity in therapeutic regimens.

Innovation Solution

A semi-sequential assay procedure involving a capture reagent immobilized on a substrate, where the analyte forms a complex with a detection reagent, which then binds to the capture reagent, utilizing a detectable moiety for analysis, and incorporating a washing solution with a non-ionic detergent to minimize non-specific interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If a conventional assay method is used for detecting anti-drug antibodies, then the detection procedure is simple, but the signal-to-noise ratio is low and sensitivity is reduced

Engineering Contradiction:
Improvesignal-to-noise ratioVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The assay is divided into distinct sequential steps: first immobilizing the capture reagent on the substrate, then adding the sample to form analyte-capture reagent complexes, and finally adding the detection reagent. This segmentation allows each step to be optimized independently, improving signal-to-noise ratio while maintaining procedural clarity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The capture reagent is pre-immobilized on the substrate before sample addition. This preliminary action ensures that the substrate surface is prepared with optimal capture reagent density and distribution, maximizing the signal-to-noise ratio when the sample is subsequently added

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If a conventional assay method is used, then the procedure is straightforward, but the sensitivity for analyte detection is low

Engineering Contradiction:
Improvedetection sensitivityVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The capture reagent acts as an intermediary between the substrate and the analyte, concentrating the analyte from the sample onto the substrate surface. This intermediary step enhances detection sensitivity by pre-concentrating the target analyte before the detection reagent is added

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The assay concentrates the detection reaction at the local level where the analyte-capture reagent complex is formed on the substrate surface. This localized concentration of the analyte and detection reagent interaction enhances sensitivity by focusing the detectable signal in a specific region rather than distributing it throughout the entire sample volume

Inventive Principle:
Principle #3Local quality

3Measurement precision

If a conventional assay method is used, then the procedure is simple, but prozone effects and hook effects occur reducing accuracy

Engineering Contradiction:
Improvedetection accuracyVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The assay uses an excess of capture reagent immobilized on the substrate, ensuring that all analyte molecules in the sample can be captured. This partial saturation approach prevents prozone effects by ensuring sufficient capture reagent is available even when analyte concentration is high, while the sequential addition of detection reagent maintains accuracy across a wide concentration range

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enhances sensitivity and reduces background noise, improving the detection of anti-drug antibodies with reduced hook effects and better tolerance for drug molecules present in the sample, allowing for more accurate assessment of immunogenicity.

Implementation Method 1

the capture reagent comprises a capturing moiety and an affinity counterpart to the analyte; and b) the capture reagent binds to the substrate via the capturing moiety and is thereby immobilized

Methodology Applied
Scientific EffectAffinity binding:

Implementation Method 2

the analyte binds to the detection reagent via the affinity counterpart to form a complex

Methodology Applied
Scientific EffectAffinity binding:

Implementation Method 3

the complex is contacted with the capture reagent immobilized on the substrate, so that the complex binds via the analyte to the capture reagent immobilized on the substrate

Methodology Applied
Scientific EffectAffinity binding:

Implementation Method 4

the detection reagent comprises a detectable moiety and an affinity counterpart to the analyte; and f) the detectable moiety is detected

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentEP2344884B1Semi-sequential assay for detection of an analyte in a sample
Publication Date: 2013.07.31 GYROS
  • EP2344884B1 patent drawingFigure 1a~1c
  • EP2344884B1 patent drawingFigure 2a~2d
  • EP2344884B1 patent drawingFigure 3a~3e

AI summary

The invention is related to a method for detection of an analyte in a sample, wherein the method is a semi-sequential assay procedure.